AG真人官方

ZOOZ Power Ltd. has filed a Rule 424(b)(5) prospectus supplement establishing a Nasdaq 鈥渁t-the-market鈥� (ATM) equity program of up to $10.95 million with Chardan Capital Markets as sales agent. Chardan will place shares on a best-efforts basis and earn a 3.0 % commission; no minimum sale amount is required.

Proceeds are earmarked to repay outstanding notes and for general corporate purposes, which may include purchasing Bitcoin or Bitcoin ETFs. At a reference price of $3.66, the program would issue roughly 3.0 million new shares, lifting total outstanding shares to about 15.1 million and diluting current holders ~25 %. ZOOZ鈥檚 public float is $32.9 million, so the raise is limited to one-third of float under Form F-3 Instruction I.B.5.

Preliminary, unaudited 1H 2025 results show $2.5 million cash, $0.2 million revenue, and an $6.0-6.1 million operating loss. The company recently adopted Bitcoin as its primary treasury reserve asset while continuing to commercialize ultra-fast EV charging and evaluate defense-sector applications for its flywheel technology.

ZOOZ qualifies as an emerging growth company and foreign private issuer, allowing reduced SEC disclosure. Extensive risk factors highlight Bitcoin price volatility, dilution, limited operating history, military conflict in Israel, and potential loss of FPI status.

GeneDx Holdings (WGS) 10-Q 鈥� quarter ended 30 Jun 2025. Revenue jumped 46 % YoY to $102.7 m, driven by third-party insured diagnostic testing (79 % of sales). Gross profit rose 65 % to $70.9 m (gross margin 69 % vs 61 %). Expense discipline and higher scale flipped operating results to a $9.0 m profit versus a $10.6 m loss last year; net income reached $10.8 m (diluted EPS $0.36) versus a $29.2 m loss (-$1.10 EPS).

Six-month view: revenue +43 % to $189.8 m and net income $4.3 m versus a $49.4 m loss. Operating cash flow turned positive at $20.6 m; however, M&A and cap-ex drove $45.8 m of investing outflow, cutting cash & equivalents to $74.1 m (total liquidity incl. securities $134.6 m).

Balance sheet: total assets $463.9 m. Stockholders鈥� equity improved to $277.1 m. Debt remains $55.1 m (Perceptive Term Loan $50 m due 2028, 7.5 %+SOFR). Goodwill/intangibles increased $34.0 m after the $36.9 m Fabric Genomics acquisition; contingent earn-out valued at $4.3 m.

Key risks: payor concentration (top two groups = 57 % of Q2 revenue, 41 % of receivables), supplier reliance, rising third-party payor reserves ($17.6 m), and high warrant exercise price ($379.50).

Outlook: Management continues to exit non-core reproductive/tumor testing and integrate Fabric鈥檚 AI interpretation platform, targeting margin expansion and cash breakeven. Liquidity appears adequate for near-term operations, but execution on revenue milestones and debt servicing will be closely watched.

Bank of Montreal (BMO) is marketing Auto-Callable Market Linked Securities with Contingent Coupons, Memory Feature and Contingent Downside Principal at Risk, linked to the worst performer among Apple Inc., Broadcom Inc. and McDonald鈥檚 Corporation. The $1,000-denominated notes price on 11 Jul 2025, settle on 16 Jul 2025 and mature on 14 Jul 2028 (3-year tenor unless called earlier).

Income profile: Investors receive a quarterly contingent coupon of at least 21.25 % p.a. (5.3125 % per quarter) provided the worst-performing underlier is 鈮� 80 % of its starting value on the relevant calculation day. The 鈥渕emory鈥� feature adds any missed coupons once the threshold is next met.

Auto-call: From Oct 2025 to Apr 2028, if the worst performer is 鈮� its starting value on a calculation day, the notes are automatically called at par plus the coupon, ending the investment early and creating reinvestment risk.

Principal repayment: If not previously called, at maturity holders receive: (i) 100 % of face if the worst performer is 鈮� 70 % of its starting value; or (ii) par 脳 performance factor of the worst performer if it is < 70 %. Investors therefore face full downside exposure below the 30 % buffer and could lose all principal.

Key structural terms: Starting values set on pricing date; coupon threshold 80 %; downside threshold 70 %; estimated initial value disclosed as $966.40 (96.64 % of face) and will not be less than $916.00. Agent discount up to 2.325 %; additional dealer fees up to 0.30 %.

Risks highlighted: conditional coupons (may receive none), potential loss of > 30 % of principal, reliance on worst performer, credit risk to BMO, illiquid secondary market, pricing transparency, and uncertain U.S. tax treatment. The notes are unsecured, not FDIC-insured and will not list on any exchange.

ZOOZ Power Ltd has filed an F-3 shelf registration statement to offer up to $30 million in securities, including ordinary shares, debt securities, rights, warrants, and units. The company's shares trade on Nasdaq (ZOOZ) and Tel Aviv Stock Exchange, with recent closing prices of $0.79 and NIS 2.8 respectively.

ZOOZ specializes in EV charging infrastructure technology, developing power-boosting systems using flywheel kinetic energy storage. Their solution enables ultra-fast EV charging in areas with limited grid power capacity, providing 2-3x power amplification compared to direct grid supply.

• Key advantages include up to 200,000 charge-discharge cycles, significantly outperforming chemical battery solutions
• Environmentally friendly alternative to chemical battery storage systems
• Helps customers overcome grid limitations for EV charging infrastructure
• Company is an emerging growth company under SEC rules

The securities will be offered on a continuous basis after effectiveness. This registration enables ZOOZ to access capital markets for growth and expansion of their EV charging infrastructure solutions.

ZOOZ Power (Nasdaq: ZOOZ) submitted a Form 6-K covering June 2025 to furnish Exhibit 99.1.

The exhibit states that the company is exploring strategic opportunities, a leading defense company has begun a proof-of-concept (POC) for ZOOZ鈥檚 flywheel-based power booster, and the Board of Directors has approved a restructuring plan. No financial data, risk factors, or legal proceedings are included in this report. The 6-K is incorporated by reference into the company鈥檚 existing Form F-1 and S-8 registration statements.

The simultaneous pursuit of strategic alternatives, validation of its technology by a defense customer, and an internal restructuring signal potentially significant operational and corporate changes. However, the filing provides no detail on scope, timing, cost, or expected financial impact, leaving investors without quantitative guidance.